EDITORIAL
Published on 06 Mar 2023
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
doi 10.3389/fonc.2023.1163144
- 775 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Moving Beyond the Molecular Mechanisms of Malignant Pleural Mesothelioma: Cues for Novel Biomarkers and Drug Targets
Moving Beyond the Molecular Mechanisms of Malignant Pleural Mesothelioma: Cues for Novel Biomarkers and Drug Targets
6,092
Total downloads
20k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 19 May 2022
Genomics of Tumor Origin and Characteristics for Adenocarcinoma and Malignant Pleural Mesothelioma: A Case Report
doi 10.3389/fonc.2022.858094
- 1,177 views
ORIGINAL RESEARCH
Published on 26 Apr 2022
A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma
doi 10.3389/fonc.2022.849640
- 2,148 views
- 4 citations
CASE REPORT
Published on 14 Mar 2022
Case Report and Review of Literature: Familial Malignant Pleural Mesothelioma in a 39 Years Old Patient With an Inconclusive 18F-FDG PET/CT Result
doi 10.3389/fsurg.2022.819596
- 2,342 views
ORIGINAL RESEARCH
Published on 27 Sep 2021
Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
doi 10.3389/fphar.2021.718675
- 3,035 views
- 8 citations
ORIGINAL RESEARCH
Published on 25 May 2021
A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors
doi 10.3389/fonc.2021.692136
- 8,768 views
- 18 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Cancer Genetics
Participating Journals
Frontiers in Genetics
Cancer GeneticsOffline
- 2.8 impact factor
- 5.5 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 20kTopic views
- 13kArticle views
- 6,092Article downloads